Literature DB >> 20404858

New insights into p53 activation.

Christopher L Brooks1, Wei Gu.   

Abstract

The tumor suppressor p53 is a multifunctional, highly regulated, and promoter-specific transcriptional factor that is uniquely sensitive to DNA damage and cellular stress signaling. The mechanisms by which p53 directs a damaged cell down either a cell growth arrest or an apoptotic pathway remain poorly understood. Evidence suggests that the in vivo functions of p53 seem to balance the cell-fate choice with the type and severity of damage that occurs. The concept of antirepression, or inhibition of factors that normally keep p53 at bay, may help explain the physiological mechanisms for p53 activation. These factors also provide novel chemotherapeutic targets for the reactivation of p53 in tumors harboring a wild-type copy of the gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20404858      PMCID: PMC3070262          DOI: 10.1038/cr.2010.53

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  90 in total

Review 1.  p53 and human cancer: the first ten thousand mutations.

Authors:  P Hainaut; M Hollstein
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

Review 2.  Telomere dysfunction and tumour suppression: the senescence connection.

Authors:  Yibin Deng; Suzanne S Chan; Sandy Chang
Journal:  Nat Rev Cancer       Date:  2008-06       Impact factor: 60.716

3.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

4.  SnapShot: p53 posttranslational modifications.

Authors:  Jan-Philipp Kruse; Wei Gu
Journal:  Cell       Date:  2008-05-30       Impact factor: 41.582

5.  Mdm2 and Mdm4 loss regulates distinct p53 activities.

Authors:  Juan A Barboza; Tomoo Iwakuma; Tamara Terzian; Adel K El-Naggar; Guillermina Lozano
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

6.  Cellular senescence bypass screen identifies new putative tumor suppressor genes.

Authors:  J F M Leal; J Fominaya; A Cascón; M V Guijarro; C Blanco-Aparicio; M Lleonart; M E Castro; S Ramon Y Cajal; M Robledo; D H Beach; A Carnero
Journal:  Oncogene       Date:  2007-10-29       Impact factor: 9.867

7.  Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition.

Authors:  Sanjeev Shangary; Dongguang Qin; Donna McEachern; Meilan Liu; Rebecca S Miller; Su Qiu; Zaneta Nikolovska-Coleska; Ke Ding; Guoping Wang; Jianyong Chen; Denzil Bernard; Jian Zhang; Yipin Lu; Qingyang Gu; Rajal B Shah; Kenneth J Pienta; Xiaolan Ling; Sanmao Kang; Ming Guo; Yi Sun; Dajun Yang; Shaomeng Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

Review 8.  An oncogene-induced DNA damage model for cancer development.

Authors:  Thanos D Halazonetis; Vassilis G Gorgoulis; Jiri Bartek
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

9.  In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute.

Authors:  E M Michalak; A Villunger; J M Adams; A Strasser
Journal:  Cell Death Differ       Date:  2008-02-08       Impact factor: 15.828

10.  Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator.

Authors:  Sonia Lain; Jonathan J Hollick; Johanna Campbell; Oliver D Staples; Maureen Higgins; Mustapha Aoubala; Anna McCarthy; Virginia Appleyard; Karen E Murray; Lee Baker; Alastair Thompson; Joanne Mathers; Stephen J Holland; Michael J R Stark; Georgia Pass; Julie Woods; David P Lane; Nicholas J Westwood
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

View more
  42 in total

1.  Protein interaction module-assisted function X (PIMAX) approach to producing challenging proteins including hyperphosphorylated tau and active CDK5/p25 kinase complex.

Authors:  Dexin Sui; Xinjing Xu; Xuemei Ye; Mengyu Liu; Maxwell Mianecki; Chotirat Rattanasinchai; Christopher Buehl; Xiexiong Deng; Min-Hao Kuo
Journal:  Mol Cell Proteomics       Date:  2014-11-10       Impact factor: 5.911

2.  Single-molecule site-specific detection of protein phosphorylation with a nanopore.

Authors:  Christian B Rosen; David Rodriguez-Larrea; Hagan Bayley
Journal:  Nat Biotechnol       Date:  2014-01-19       Impact factor: 54.908

3.  Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.

Authors:  Antonella Tramutola; Gilda Pupo; Fabio Di Domenico; Eugenio Barone; Andrea Arena; Chiara Lanzillotta; Diede Brokeaart; Carla Blarzino; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

4.  Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation.

Authors:  Zhen-Ning Zhang; Sun-Ku Chung; Zheng Xu; Yang Xu
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

5.  A novel, semi-synthetic diterpenoid 16(R and S)-phenylamino-cleroda-3,13(14), Z-dien-15,16 olide (PGEA-AN) inhibits the growth and cell survival of human neuroblastoma cell line SH-SY5Y by modulating P53 pathway.

Authors:  Syed Saad Hussain; Kinza Rafi; Shaheen Faizi; Zaid Abdul Razzak; Shabana U Simjee
Journal:  Mol Cell Biochem       Date:  2018-04-11       Impact factor: 3.396

6.  Critical role of presenilin-dependent γ-secretase activity in DNA damage-induced promyelocytic leukemia protein expression and apoptosis.

Authors:  H Song; J Hyun Boo; K Ho Kim; C Kim; Y-E Kim; J-H Ahn; G Sun Jeon; H Ryu; D E Kang; I Mook-Jung
Journal:  Cell Death Differ       Date:  2013-01-11       Impact factor: 15.828

7.  hSSB1 regulates both the stability and the transcriptional activity of p53.

Authors:  Shuangbing Xu; Yuanzhong Wu; Qiong Chen; Jingying Cao; Kaishun Hu; Jianjun Tang; Yi Sang; Fenju Lai; Li Wang; Ruhua Zhang; Sheng-Ping Li; Yi-Xin Zeng; Yuxin Yin; Tiebang Kang
Journal:  Cell Res       Date:  2012-11-27       Impact factor: 25.617

8.  Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition.

Authors:  Xiaolei Xie; Li Le; Yanxin Fan; Lin Lv; Junjie Zhang
Journal:  Autophagy       Date:  2012-05-11       Impact factor: 16.016

9.  HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53-dependent mitochondrial apoptosis.

Authors:  Marilena Castelli; Danilo Piobbico; Martina Chiacchiaretta; Cinzia Brunacci; Stefania Pieroni; Daniela Bartoli; Marco Gargaro; Francesca Fallarino; Paolo Puccetti; Silvia Soddu; Maria Agnese Della-Fazia; Giuseppe Servillo
Journal:  EMBO Rep       Date:  2019-12-23       Impact factor: 8.807

10.  Puma, noxa, p53, and p63 differentially mediate stress pathway induced apoptosis.

Authors:  Jun Wang; Holly R Thomas; Zhang Li; Nan Cher Florence Yeo; Hannah E Scott; Nghi Dang; Mohammed Iqbal Hossain; Shaida A Andrabi; John M Parant
Journal:  Cell Death Dis       Date:  2021-06-30       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.